Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
- Conditions
- Subarachnoid HemorrhageIntracerebral Hemorrhage
- Registration Number
- NCT00490464
- Lead Sponsor
- University of Illinois at Chicago
- Brief Summary
The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 163
- 18-70 years old (inclusive)
- Admission to NSICU with a diagnosis of SAH or ICH
- Patients who are admitted >48 hours after SAH or ICH
- Readmission or second SAH
- Readmission or second ICH
- Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage
- Women who are pregnant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Illinois at Chicago, UIC
🇺🇸Chicago, Illinois, United States
University of Illinois at Chicago, UIC🇺🇸Chicago, Illinois, United States